14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.197 2 days ( 3.31 % )
Last Price $1.17 -3.31 %
High/ Low $1.17 - $1.23 4.27%
Chg 7 Days -2.50 % $1.20 $1.17
Chg 30 Days -16.43 % $1.40 $1.17
Chg 12 mos -30.36 % $1.68 $1.17
Trend - 3 mos -9.09 % Width: 47.79 %
Trend - 12 mos -44.12 % Width: 520.01 %
Pred. range - 3 mos $0.97 - $1.43 -17.45 % - 22.00 %
Pred. range - 12 mos $0.175 - $1.08 -85.05 % - -7.32 %
Short MA avg 3 mos Sell May 03, 2024 - 2 days
Long MA avg 3 mos Sell Apr 05, 2024 - 22 days
Short/Long MA avg 3 mos Sell Apr 11, 2024 - 18 days
Short MA avg 12 mos Sell Apr 05, 2024 - 22 days
Long MA avg 12 mos Sell Apr 08, 2024 - 21 days
Short/Long MA avg 12 mos Sell Apr 23, 2024 - 10 days
Pivot Short Sell Apr 22, 2024 - 11 days
Bollinger Buy Mar 20, 2024 - 33 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Hoth Therapeutics Inc.

Hoth Therapeutics. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ... HOTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT